Exclusive: Neuralink’s Brain Implant Faces Hiccups in Human Trial
LA News Center has obtained exclusive information on Neuralink’s ongoing human trials for their groundbreaking brain-computer interface (BCI) technology.
Promising Progress
Neuralink’s vision is to create a device that allows paralyzed individuals to control technology with their thoughts. The company’s BCI, dubbed “Link,” employs 1,024 electrodes woven into 64 hair-thin “threads” implanted in the brain.
In January, Neuralink implanted Link into the brain of 29-year-old Noland Arbaugh. The surgery was reportedly successful, and Arbaugh later showcased the device’s functionality in a live demonstration.
Unexpected Setback
However, in a recent blog post, Neuralink acknowledged a setback: several threads have retracted from Arbaugh’s brain, reducing the number of active electrodes. This has impacted the system’s ability to translate signals into cursor movements accurately and efficiently.
The company has been quick to address the issue, modifying the recording algorithm and refining the user interface. Neuralink reportedly considered removing the implant, but The Wall Street Journal reports that the malfunction does not pose an immediate risk to Arbaugh’s safety.
Still in Development
Neuralink has always emphasized the experimental nature of its technology. BCI systems are still in their early stages of development, and setbacks are to be expected during clinical trials.
Despite the hiccup, Arbaugh has remained positive, using the Link device for several hours daily. He describes it as a “luxury overload” that has helped him reconnect with the world.
The Road Ahead
Neuralink faces a rigorous path of safety and efficacy testing before securing regulatory approval from the U.S. Food and Drug Administration. The company has acknowledged the challenges but remains confident in the potential of its technology to transform the lives of individuals with paralysis.
While Neuralink’s setback serves as a reminder of the complexities of BCI development, it also underscores the relentless pursuit of innovation in this exciting field.
Data sourced from: cnbc.com
